A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Colorectal CancerCholangiocarcinoma
Interventions
DEVICE

Medtronic pump and Codman catheter

All patients will undergo surgery to have the Medtronic pump and Codman catheter placed appropriately before HAI therapy can begin.

DRUG

Floxuridine (FUDR)

Please see Detailed Description.

DRUG

Gemcitabine

Please see Detailed Description.

DRUG

Oxaliplatin

Please see Detailed Description.

DRUG

Irinotecan (CPT-11)

Please see Detailed Description.

DRUG

Fluorouracil

Please see Detailed Description.

DRUG

Anti-EGFR (Panitumumab or Cetuximab)

Please see Detailed Description.

Trial Locations (1)

98101

RECRUITING

Virginia mason medical Center, Seattle

Sponsors
All Listed Sponsors
collaborator

Virginia Mason Hospital/Medical Center

OTHER

lead

Benaroya Research Institute

OTHER